Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research

The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research

Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research

Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research

The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research

Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research

Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research

The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research

Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research

Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research

The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research

Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer
Conclusion: Good LIPI correlated with better outcomes for patients with MGC in the anti-PD-1-treated group but not in the chemotherapy-treated group.PMID:38085163 | DOI:10.2217/bmm-2023-0052 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Miaomiao Gou Yong Zhang Tongtong Qu Ru Jia Zhikuan Wang Guanghai Dai Source Type: research

Neutrophil-to-serum iron ratio as a promising inflammatory biomarker for acute myocardial infarction and Gensini score
Conclusion: N/SI was discovered to be a new and effective inflammatory biomarker for AMI and Gensini score.PMID:38085167 | DOI:10.2217/bmm-2023-0177 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Jiedong Ma Xiaojin Liu Hongqi Zhang Yufei Chen Jiamin Tian Wei Shen Source Type: research

Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer
Conclusion: Good LIPI correlated with better outcomes for patients with MGC in the anti-PD-1-treated group but not in the chemotherapy-treated group.PMID:38085163 | DOI:10.2217/bmm-2023-0052 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Miaomiao Gou Yong Zhang Tongtong Qu Ru Jia Zhikuan Wang Guanghai Dai Source Type: research

Neutrophil-to-serum iron ratio as a promising inflammatory biomarker for acute myocardial infarction and Gensini score
Conclusion: N/SI was discovered to be a new and effective inflammatory biomarker for AMI and Gensini score.PMID:38085167 | DOI:10.2217/bmm-2023-0177 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Jiedong Ma Xiaojin Liu Hongqi Zhang Yufei Chen Jiamin Tian Wei Shen Source Type: research